Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 5, 2019Journal of Medicinal ChemistryOpen Access

Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

View Full Paper
Ask AI
Bookmark
Share

Authors

YGYunhang GuoBeijing Normal UniversityYLYe LiuShanghai Changzheng HospitalNHNan HuSingapore Management University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Guo et al. (2019) studied this question.

synapsesocial.com/papers/69d9b84f2a25b240b7a3d970https://doi.org/10.1021/acs.jmedchem.9b00687
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tec regulates platelet activation by GPVI in the absence of Btk2003 · 167 citations
  2. 2Phaser crystallographic software2007 · 21,403 citations
  3. 3Src family kinases: at the forefront of platelet activation2014 · 302 citations
  4. 4Coot : model-building tools for molecular graphics2004 · 31,865 citations
  5. 5Supportive Care Treatments for Toxicities of Anti-EGFR and Other Targeted Agents2012 · 39 citations